| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $64.61M | - | |
| VP | 66.5K | $32.19M | - | |
| VP | 51.1K | $24.72M | - | |
| VP | 42.3K | $20.47M | - | |
| Other | 24.0K | $11.63M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Bozic Carmen53 | EVP And CMO | Sell | 2,280 | $471.72 | $1,075,521.60 | -7.0% | -2.3% | -6.5% | |
| Jun 12, 2024 | Bozic Carmen53 | EVP And CMO | Sell | 2,280 | $478.00 | $1,089,840.00 | -6.6% | -1.1% | -3.3% | |
| Jun 12, 2024 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 7,288 | $478.00 | $3,483,664.00 | -31.3% | -1.1% | -3.3% | |
| Jun 3, 2024 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 2,175 | $460.00 | $1,000,500.00 | -4.2% | +1.2% | -5.0% | |
| Jun 3, 2024 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 3,250 | $460.00 | $1,495,000.00 | -6.5% | +1.2% | -5.0% | |
| May 31, 2024 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 4,600 | $441.99 | $2,033,158.50 | -4.2% | +8.3% | -2.9% | |
| May 29, 2024 | Bozic Carmen53 | EVP And CMO | Sell | 2,280 | $445.56 | $1,015,876.80 | -6.2% | +8.9% | +1.4% | |
| May 28, 2024 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 3,250 | $454.79 | $1,478,067.50 | -6.1% | +8.0% | -0.4% | |
| May 24, 2024 | Kewalramani Reshma55 | CEO &President | Sale+OE | 1,565 | $457.00 | $715,205.00 | -1.3% | +5.0% | -4.6% | |
| May 22, 2024 | Sachs Bruce I51 | Director | Sale+OE | 7,073 | $448.00 | $3,168,704.00 | -15.0% | +8.9% | -3.0% |